Does SECUKINUMAB Cause Dermatitis exfoliative? 48 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Dermatitis exfoliative have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.0% of all adverse event reports for SECUKINUMAB.
48
Reports of Dermatitis exfoliative with SECUKINUMAB
0.0%
of all SECUKINUMAB reports
3
Deaths
20
Hospitalizations
How Dangerous Is Dermatitis exfoliative From SECUKINUMAB?
Of the 48 reports, 3 (6.3%) resulted in death, 20 (41.7%) required hospitalization, and 2 (4.2%) were considered life-threatening.
Is Dermatitis exfoliative Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 48 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Dermatitis exfoliative?
CIPROFLOXACIN (91)
ALLOPURINOL (86)
SULFAMETHOXAZOLE\TRIMETHOPRIM (75)
CLOPIDOGREL BISULFATE (73)
FUROSEMIDE (73)
ATORVASTATIN (71)
AMLODIPINE (70)
ACETAMINOPHEN (66)
VANCOMYCIN (66)
SIMVASTATIN (64)
Which SECUKINUMAB Alternatives Have Lower Dermatitis exfoliative Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG